Novel heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators
申请人:——
公开号:US20040259915A1
公开(公告)日:2004-12-23
The present invention is directed to novel heteroatom containing tetracyclic derivatives, pharmaceutical compositions containing them, their use in the treatment and/or prevention of disorders mediated by one or more estrogen receptors and processes for their preparation. The compounds of the invention are useful in the treatment and/or prevention of disorders associated with the depletion of estrogen such as hot flashes, vaginal dryness, osteopenia and osteoporosis; hormone sensitive cancers and hyperplasia of the breast, endometrium, cervix and prostate; endometriosis, uterine fibroids, osteoarthritis and as contraceptive agents, alone or in combination with a progestogen or progestogen antagonist.
本发明涉及新颖的含杂原子四环衍生物、含有它们的药物组合物、它们在治疗和/或预防由一个或多个雌激素受体介导的疾病中的应用,以及它们的制备方法。本发明的化合物在治疗和/或预防与雌激素耗竭相关的疾病中具有用途,例如热潮红、阴道干燥、骨量减少和骨质疏松症;激素敏感性癌症以及乳腺、子宫内膜、宫颈和前列腺的增生;子宫内膜异位症、子宫肌瘤、骨关节炎,以及作为避孕剂,单独使用或与孕激素或孕激素拮抗剂联合使用。